Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-25 @ 1:23 AM
NCT ID:
NCT03514693
Eligibility Criteria:
Inclusion Criteria:
* Patients undergoing a first-time ablation procedure for persistent AF
Exclusion Criteria:
* Patients with long-standing persistent AF lasting ≥ 5 years
* Patients with left atrial dimension ≥ 50 mm by 2-dimensional echocardiography
* Patients with valvular AF (defined as the presence of mitral or aortic stenosis or regurgitation with a history of rheumatic fever or implantation of artificial heart valves)
* Patients who underwent prior cardiac surgery
* Patients receiving hemodialysis
* Patients with heart failure (left ventricular ejection fraction \< 30% and NYHA class ≥ III)
* Patients receiving antiarrhythmic agents before the ablation procedure (within 60 days for amiodarone, or 5 half-lives for other drugs)
* Patients who are not considered to be suitable candidates by the attending physician
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT03514693
Study Brief:
Protocol Section:
NCT03514693